Patents by Inventor Anthony W. Czarnik

Anthony W. Czarnik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MULTIPLEX DECODING OF ARRAY SENSORS WITH MICROSPHERES
    Publication number: 20130310280
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Application
    Filed: May 13, 2013
    Publication date: November 21, 2013
    Applicant: Illumina, Inc
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
  • DEUTERIUM-ENRICHED LENALIDOMIDE
    Publication number: 20130245067
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 9, 2012
    Publication date: September 19, 2013
    Applicant: DEUTERIA PHARMACEUTICALS, INC.
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched bupropion
    Patent number: 8524780
    Abstract: The present application describes deuterium-enriched bupropion, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: May 19, 2010
    Date of Patent: September 3, 2013
    Assignee: DeuteRx, LLC
    Inventor: Anthony W. Czarnik
  • Multiplex decoding of array sensors with microspheres
    Patent number: 8460865
    Abstract: The invention relates to compositions and methods for multiplex decoding of microsphere array sensors.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: June 11, 2013
    Assignee: Illumina, Inc.
    Inventors: Mark S. Chee, John R. Stuelpnagel, Anthony W. Czarnik
  • Deuterium-enriched donepezil
    Patent number: 8304435
    Abstract: The present application describes deuterium-enriched donepezil, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: November 6, 2012
    Assignee: Deuteria Pharmaceuticals Inc.
    Inventor: Anthony W Czarnik
  • Deuterium-enriched lenalidomide
    Patent number: 8288414
    Abstract: The present application describes deuterium-enriched lenalidomide, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: October 16, 2012
    Assignee: Deuteria Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RUBOXISTAURIN
    Publication number: 20120136037
    Abstract: The present application describes deuterium-enriched ruboxistaurin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: September 3, 2008
    Publication date: May 31, 2012
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED MEROPENEM
    Publication number: 20120122833
    Abstract: The present application describes deuterium-enriched meropenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: May 17, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED IXABEPILONE
    Publication number: 20120035227
    Abstract: The present application describes deuterium-enriched ixabepilone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 3, 2011
    Publication date: February 9, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SAXAGLIPTIN
    Publication number: 20120035261
    Abstract: The present application describes deuterium-enriched saxagliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 3, 2011
    Publication date: February 9, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DASATINIB
    Publication number: 20120015956
    Abstract: The present application describes deuterium-enriched dasatinib, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: December 9, 2010
    Publication date: January 19, 2012
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ALOGLIPTIN
    Publication number: 20110312983
    Abstract: The present application describes deuterium-enriched alogliptin, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: December 9, 2010
    Publication date: December 22, 2011
    Applicant: Protia, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED TOLTERODINE
    Publication number: 20110281952
    Abstract: The present application describes deuterium-enriched tolterodine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 17, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DORIPENEM
    Publication number: 20110281927
    Abstract: The present application describes deuterium-enriched doripenem, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: November 11, 2010
    Publication date: November 17, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched topotecan
    Patent number: 8026249
    Abstract: The present application describes deuterium-enriched topotecan, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: September 27, 2011
    Assignee: Deutena Pharmaceuticals, Inc.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED RISPERIDONE
    Publication number: 20110212976
    Abstract: The present application describes deuterium-enriched risperidone, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: July 5, 2010
    Publication date: September 1, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED DAPOXETINE
    Publication number: 20110201690
    Abstract: The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: August 18, 2010
    Publication date: August 18, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED SDX-101
    Publication number: 20110160270
    Abstract: The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: March 7, 2011
    Publication date: June 30, 2011
    Applicant: PROTIA, LLC.
    Inventor: Anthony W. Czarnik
  • DEUTERIUM-ENRICHED ODANSETRON
    Publication number: 20110144174
    Abstract: The present application describes deuterium-enriched ondansetron, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Application
    Filed: February 28, 2011
    Publication date: June 16, 2011
    Applicant: PROTIA, LLC
    Inventor: Anthony W. Czarnik
  • Deuterium-enriched SDX-101
    Patent number: 7956080
    Abstract: The present application describes deuterium-enriched SDX-101, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.
    Type: Grant
    Filed: September 18, 2008
    Date of Patent: June 7, 2011
    Assignee: Protra, LLC
    Inventor: Anthony W. Czarnik